Robert Friesen
Keine laufenden Positionen mehr
Karriereverlauf von Robert Friesen
Ehemalige bekannte Positionen von Robert Friesen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| KIADIS PHARMA N.V. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2019 | 01.08.2021 |
| ABLYNX | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2018 | 01.01.2019 |
| PROQR THERAPEUTICS N.V. | Corporate Officer/Principal | 01.06.2016 | 01.02.2018 |
Janssen Research & Development LLC
 Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Corporate Officer/Principal | 01.05.2014 | 01.06.2016 |
| MORPHOSYS AG | Corporate Officer/Principal | 01.05.2005 | 01.07.2008 |
| PHARMING GROUP N.V. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2021 | - |
| Janssen Biotherapeutics | Corporate Officer/Principal | - | - |
Ausbildung von Robert Friesen
| The University of Texas at Austin | Doctorate Degree |
| University of Utrecht | Graduate Degree |
Statistik
International
| Niederlande | 5 |
| Vereinigte Staaten | 3 |
| Belgien | 3 |
Operativ
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| PROQR THERAPEUTICS N.V. | Health Technology |
| MORPHOSYS AG | Health Technology |
| PHARMING GROUP N.V. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Commercial Services |
Kiadis Pharma NV
 Kiadis Pharma NV Pharmaceuticals: MajorHealth Technology Kiadis Pharma NV engages in pharmaceutical development of cell-based immunotherapy products in the field of diseases of the blood building system. Its lead product is the ATIR101. The company was founded in 1997 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
| Janssen Biotherapeutics |
- Börse
- Insiders
- Robert Friesen
- Erfahrung
